Graduate School of Frontier Sciences, The University of Tokyo Department of
Integrated Biosciences

At the Kashiwa Campus of the National Cancer Center Japan (Hospital East and Exploratory Oncology Research and Clinical Trial Center), various clinical trials developing cancer treatment and diagnosis are being conducted, and high-quality clinical information is being accumulated. Using patient samples related to these clinical trials, multi-omics analyses such as single cell analysis, spatial transcriptome analysis, and microbiome analysis are being conducted within the center and in collaboration with laboratories at the Graduate School of Frontier Sciences, the University of Tokyo. These data are shared not only with researchers in academia, but also with pharmaceutical companies to identify new therapeutic targets and biomarkers. Furthermore, it is expected that various devices will be used to collect and utilize subjective symptoms and continuous vital data of the patients, which have been difficult to quantify. This information on the health status of individuals is essential for the development of future treatment and diagnosis methods, but at the same time, it must be strictly managed as personal information.

We would like to clarify what kind of technology is needed to build a safe, efficient, and consistent platform from data collection and management to efficient extraction of relevant information and visualization.